Bullish option flow detected in Aurinia Pharmaceuticals with 3,353 calls trading, 4x expected, and implied vol increasing almost 5 points to 116.46%. Jan-23 8 calls and Apr-23 8 calls are the most active options, with total volume in those strikes near 1,000 contracts. The Put/Call Ratio is 0.21. Earnings are expected on February 28th.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on AUPH:
- Aurinia Pharmaceuticals backs FY23 net product revenue view $120M-$140M
- Aurinia Pharmaceuticals reports preliminary net FY22 revenue $134M
- Aurinia Pharmaceuticals reports preliminary Q4 revenue $28.4M, consensus $26.97M
- Biotech Alert: Searches spiking for these stocks today
- Aurinia worth ‘keeping closer eye on’ after settlement, Dealreporter says